Propanc is currently focused on developing new cancer treatments for patients suffering from pancreatic, ovarian and colorectal cancers. We have developed a formulation of anti-cancer compounds which exert a number of effects designed to control or prevent tumors from recurring and spreading throughout the body. Our products involve or employ proenzymes, which are inactive precursors of enzymes.View Scientific Whitepaper
Propanc Biopharma, Inc.
Securities Transfer Corporation
2901 N. Dallas Parkway
Plano, Texas 75093